247 related articles for article (PubMed ID: 29699790)
21. Oxidized Carbon Nanosphere-Based Subunit Vaccine Delivery System Elicited Robust Th1 and Cytotoxic T Cell Responses.
Sawutdeechaikul P; Cia F; Bancroft G; Wanichwecharungruang S; Sittplangkoon C; Palaga T
J Microbiol Biotechnol; 2019 Mar; 29(3):489-499. PubMed ID: 30691253
[TBL] [Abstract][Full Text] [Related]
22. Potentiation of Th1-Type Immune Responses to
Ko A; Wui SR; Ryu JI; Lee YJ; Hien DTT; Rhee I; Shin SJ; Park SA; Kim KS; Cho YJ; Lee NG
J Microbiol Biotechnol; 2018 Jan; 28(1):136-144. PubMed ID: 29081214
[TBL] [Abstract][Full Text] [Related]
23. Immunological characterization of chimeras of high specificity antigens from Mycobacterium tuberculosis H37Rv.
Fatma F; Tripathi DK; Srivastava M; Srivastava KK; Arora A
Tuberculosis (Edinb); 2021 Mar; 127():102054. PubMed ID: 33550109
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary Administration of the Liposome-Based Adjuvant CAF01: Effect of Surface Charge on Mucosal Adjuvant Function.
Müllertz OAO; Andersen P; Christensen D; Foged C; Thakur A
Mol Pharm; 2023 Feb; 20(2):953-970. PubMed ID: 36583936
[TBL] [Abstract][Full Text] [Related]
25. CD4 and CD8 T cell responses to the M. tuberculosis Ag85B-TB10.4 promoted by adjuvanted subunit, adenovector or heterologous prime boost vaccination.
Elvang T; Christensen JP; Billeskov R; Thi Kim Thanh Hoang T; Holst P; Thomsen AR; Andersen P; Dietrich J
PLoS One; 2009; 4(4):e5139. PubMed ID: 19357780
[TBL] [Abstract][Full Text] [Related]
26. Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System.
Ciabattini A; Pettini E; Fiorino F; Lucchesi S; Pastore G; Brunetti J; Santoro F; Andersen P; Bracci L; Pozzi G; Medaglini D
Front Immunol; 2018; 9():380. PubMed ID: 29593710
[TBL] [Abstract][Full Text] [Related]
27. Synchronization of dendritic cell activation and antigen exposure is required for the induction of Th1/Th17 responses.
Kamath AT; Mastelic B; Christensen D; Rochat AF; Agger EM; Pinschewer DD; Andersen P; Lambert PH; Siegrist CA
J Immunol; 2012 May; 188(10):4828-37. PubMed ID: 22504654
[TBL] [Abstract][Full Text] [Related]
28. Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis.
Bennekov T; Dietrich J; Rosenkrands I; Stryhn A; Doherty TM; Andersen P
Eur J Immunol; 2006 Dec; 36(12):3346-55. PubMed ID: 17109467
[TBL] [Abstract][Full Text] [Related]
29. Mucosal delivery switches the response to an adjuvanted tuberculosis vaccine from systemic TH1 to tissue-resident TH17 responses without impacting the protective efficacy.
Orr MT; Beebe EA; Hudson TE; Argilla D; Huang PW; Reese VA; Fox CB; Reed SG; Coler RN
Vaccine; 2015 Nov; 33(48):6570-8. PubMed ID: 26541135
[TBL] [Abstract][Full Text] [Related]
30. Efficacy Testing of H56 cDNA Tattoo Immunization against Tuberculosis in a Mouse Model.
Platteel ACM; Nieuwenhuizen NE; Domaszewska T; Schürer S; Zedler U; Brinkmann V; Sijts AJAM; Kaufmann SHE
Front Immunol; 2017; 8():1744. PubMed ID: 29312295
[TBL] [Abstract][Full Text] [Related]
31. A multistage mycobacterium tuberculosis subunit vaccine LT70 including latency antigen Rv2626c induces long-term protection against tuberculosis.
Liu X; Peng J; Hu L; Luo Y; Niu H; Bai C; Wang Q; Li F; Yu H; Wang B; Chen H; Guo M; Zhu B
Hum Vaccin Immunother; 2016 Jul; 12(7):1670-7. PubMed ID: 26901244
[TBL] [Abstract][Full Text] [Related]
32. The in vivo expressed Mycobacterium tuberculosis (IVE-TB) antigen Rv2034 induces CD4⁺ T-cells that protect against pulmonary infection in HLA-DR transgenic mice and guinea pigs.
Commandeur S; van den Eeden SJ; Dijkman K; Clark SO; van Meijgaarden KE; Wilson L; Franken KL; Williams A; Christensen D; Ottenhoff TH; Geluk A
Vaccine; 2014 Jun; 32(29):3580-8. PubMed ID: 24837764
[TBL] [Abstract][Full Text] [Related]
33. Adenylate kinase: a novel antigen for immunodiagnosis and subunit vaccine against tuberculosis.
Xiao Y; Sha W; Tian Z; Chen Y; Ji P; Sun Q; Wang H; Wang S; Fang Y; Wen HL; Zhao HM; Lu J; Xiao H; Fan XY; Shen H; Wang Y
J Mol Med (Berl); 2016 Jul; 94(7):823-34. PubMed ID: 26903285
[TBL] [Abstract][Full Text] [Related]
34. Development of a thermostable spray dried outer membrane vesicle pertussis vaccine for pulmonary immunization.
Kanojia G; Raeven RHM; van der Maas L; Bindels THE; van Riet E; Metz B; Soema PC; Ten Have R; Frijlink HW; Amorij JP; Kersten GFA
J Control Release; 2018 Sep; 286():167-178. PubMed ID: 30048656
[TBL] [Abstract][Full Text] [Related]
35. Alarmin IL-33 elicits potent TB-specific cell-mediated responses.
Villarreal DO; Siefert RJ; Weiner DB
Hum Vaccin Immunother; 2015; 11(8):1954-60. PubMed ID: 26091147
[TBL] [Abstract][Full Text] [Related]
36. A multi-subunit Chlamydia vaccine inducing neutralizing antibodies and strong IFN-γ⁺ CMI responses protects against a genital infection in minipigs.
Bøje S; Olsen AW; Erneholm K; Agerholm JS; Jungersen G; Andersen P; Follmann F
Immunol Cell Biol; 2016 Feb; 94(2):185-95. PubMed ID: 26268662
[TBL] [Abstract][Full Text] [Related]
37. A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human.
van Dissel JT; Joosten SA; Hoff ST; Soonawala D; Prins C; Hokey DA; O'Dee DM; Graves A; Thierry-Carstensen B; Andreasen LV; Ruhwald M; de Visser AW; Agger EM; Ottenhoff TH; Kromann I; Andersen P
Vaccine; 2014 Dec; 32(52):7098-107. PubMed ID: 25454872
[TBL] [Abstract][Full Text] [Related]
38. A multistage-polyepitope vaccine protects against Mycobacterium tuberculosis infection in HLA-DR3 transgenic mice.
Geluk A; van den Eeden SJ; van Meijgaarden KE; Dijkman K; Franken KL; Ottenhoff TH
Vaccine; 2012 Dec; 30(52):7513-21. PubMed ID: 23103299
[TBL] [Abstract][Full Text] [Related]
39. Mucosal delivery of antigen-coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice.
Stylianou E; Diogo GR; Pepponi I; van Dolleweerd C; Arias MA; Locht C; Rider CC; Sibley L; Cutting SM; Loxley A; Ma JK; Reljic R
Eur J Immunol; 2014 Feb; 44(2):440-9. PubMed ID: 24214530
[TBL] [Abstract][Full Text] [Related]
40. Protein energy malnutrition during vaccination has limited influence on vaccine efficacy but abolishes immunity if administered during Mycobacterium tuberculosis infection.
Hoang T; Agger EM; Cassidy JP; Christensen JP; Andersen P
Infect Immun; 2015 May; 83(5):2118-26. PubMed ID: 25754202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]